AUPH - Aurinia Pharmaceuticals sees strong Q4 revenue growth eyes cash flow positivity
2024-01-05 07:27:02 ET
More on Aurinia Pharma
- Aurinia Pharmaceuticals: A Post Q3 Earnings Assessment
- Aurinia Pharmaceuticals Inc. (AUPH) Q3 2023 Earnings Call Transcript
- Aurinia Pharma goes negative even amid takeover speculation
- Aurinia partner files for Japan approval of lupus nephritis drug
- Seeking Alpha’s Quant Rating on Aurinia Pharma
For further details see:
Aurinia Pharmaceuticals sees strong Q4 revenue growth, eyes cash flow positivity